SCHEMBL15038398

SCHEMBL15038398

c1ccc(-c2cccc(N(c3cccc(-c4cccc(-c5ccc6c(c5)oc5ccccc56)c4)c3)c3ccccc3-c3ccccc3)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 4/20 0.39
▸ PLA2G4A P47712 4/20 0.39
▸ MMP12 P39900 1/20 0.39
▸ MMP13 P45452 1/20 0.39
▸ HCRTR1 O43613 1/20 0.38
▸ AHR P35869 2/20 0.37
▸ PLA2G10 O15496 1/20 0.37
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ ALOX5 P09917 1/20 0.36
▸ NPC1 O15118 3/20 0.34
▸ RAB9A P51151 3/20 0.34
▸ ATM Q13315 1/20 0.34
▸ PRKDC P78527 2/20 0.34
▸ HSD17B1 P14061 1/20 0.32
▸ HSD17B2 P37059 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15038411 0.99 MMP12 (0.40) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL15038393 0.97 HCRTR1 (0.39) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL17720613 0.96 PLA2G2A (0.39) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL17720651 0.95 AHR (0.37) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL17720625 0.94 PLA2G2A (0.39) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL24472582 0.93 ALOX5 (0.37) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL24472353 0.93 MMP12 (0.38) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL24472306 0.93 MMP12 (0.38) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL24472310 0.93 MMP12 (0.38) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL24472350 0.93 MMP12 (0.38) PLA2G2APLA2G4AMMP12MMP13HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2826079-B1 ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2021-01-20 — — EP disclosed
US-10665787-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2020-05-26 — — US disclosed
EP-3230402-B1 ELECTRONIC DEVICE MERCK PATENT GMBH (DE) 2020-04-15 — — EP disclosed
US-10454040-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2019-10-22 — — US disclosed
US-10424739-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2019-09-24 — — US disclosed
US-10381576-B2 Electronic device having an amine containing layer processed from solution MERCK PATENT GMBH (DE) 2019-08-13 — — US disclosed
EP-3460864-A1 ELECTRONIC DEVICES Merck Patent GmbH (DE) 2019-03-27 — — EP disclosed
US-10193094-B2 Organic light-emitting device having delayed fluorescence MERCK PATENT GMBH (DE) 2019-01-29 — — US disclosed
US-10008672-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2018-06-26 — — US disclosed
US-10008672-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2018-06-26 — — US disclosed
US-20150340619-A1 Electronic Device MERCK PATENT GMBH (DE) 2015-11-26 — — US disclosed
US-20150236261-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2015-08-20 — — US disclosed
US-20150236261-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2015-08-20 — — US disclosed
US-20150115239-A1 ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2015-04-30 — — US disclosed
US-20150115239-A1 ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2015-04-30 — — US disclosed
US-20140312287-A1 Compounds for Electronic Devices MERCK PATENT GMBH (DE) 2014-10-23 — — US disclosed
US-20140312287-A1 Compounds for Electronic Devices MERCK PATENT GMBH (DE) 2014-10-23 — — US disclosed
WO-2014106521-A1 ELECTRONIC DEVICE MERCK PATENT GMBH (DE) 2014-07-10 — — WO disclosed
WO-2014044344-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2014-03-27 — — WO disclosed
WO-2013087142-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2013-06-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10008672-B2 Compounds for electronic devices KCNQ2, DDT, KCNQ1 PLA2G2A 4484/4885PLA2G4A 4768/4885MMP12 3889/4885
US-10424739-B2 Compounds for electronic devices KCNQ2, DDT, KCNQ1 PLA2G2A 4484/4885PLA2G4A 4768/4885MMP12 3889/4885
US-10665787-B2 Compounds for electronic devices KCNQ2, DDT, KCNQ1 PLA2G2A 4484/4885PLA2G4A 4768/4885MMP12 3889/4885
US-10381576-B2 Electronic device having an amine containing layer processed from solution OCIAD1, OCIAD2, AOC2 PLA2G2A 1569/4885PLA2G4A 2202/4885MMP12 3241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback